Search by Drug Name or NDC

    NDC 58657-0505-08 Guaifenesin and Dextromethorphan Hydrobromide 10; 100 mg/5mL; mg/5mL Details

    Guaifenesin and Dextromethorphan Hydrobromide 10; 100 mg/5mL; mg/5mL

    Guaifenesin and Dextromethorphan Hydrobromide is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by Method Pharmaceuticals. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.

    Product Information

    NDC 58657-0505
    Product ID 58657-505_0c5adf4a-963a-2810-e063-6394a90aed54
    Associated GPIs 43997002521220
    GCN Sequence Number 016414
    GCN Sequence Number Description guaifenesin/dextromethorphan SYRUP 100-10MG/5 ORAL
    HIC3 B3T
    HIC3 Description NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION
    GCN 53495
    HICL Sequence Number 000223
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR
    Brand/Generic Generic
    Proprietary Name Guaifenesin and Dextromethorphan Hydrobromide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Guaifenesin and Dextromethorphan Hydrobromide
    Product Type HUMAN OTC DRUG
    Dosage Form SYRUP
    Route ORAL
    Active Ingredient Strength 10; 100
    Active Ingredient Units mg/5mL; mg/5mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
    Labeler Name Method Pharmaceuticals
    Pharmaceutical Class Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 58657-0505-08 (58657050508)

    NDC Package Code 58657-505-08
    Billing NDC 58657050508
    Package 237 mL in 1 BOTTLE, PLASTIC (58657-505-08)
    Marketing Start Date 2016-06-14
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.02343
    Pricing Unit ML
    Effective Date 2022-11-23
    NDC Description GUAIFENESIN DM SYRUP
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis